Gene: FAM167A

83648
C8orf13|D8S265
family with sequence similarity 167 member A
protein-coding
8p23.1
Ensembl:ENSG00000154319 MIM:610085 Vega:OTTHUMG00000129361 UniprotKB:Q96KS9
NC_000008.11
PubMed|SNP Mapped
ND|AD
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.988e-1 (AD)  4.281e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs4310165chr8:11437066 (GRCh38.p7)C>A / C>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SLC1A20.896
EZR0.892
SLC4A40.887
FGFR30.887
ACSBG10.883
MLC10.882
NR2E10.879
BMP70.876
ARHGEF260.875
NTRK20.87

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CACNA1F-0.407
NRG1-0.406
TBC1D8B-0.388
RSPO3-0.385
AK7-0.385
PAQR9-0.385
FOXP2-0.384
CHN2-0.382
FGF10-0.38
DEPDC1B-0.377

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
D000082AcetaminophenAcetaminophen results in increased expression of FAM167A mRNA29067470
D020106AcrylamideAcrylamide results in increased expression of FAM167A mRNA28959563
D001280AtrazineAtrazine results in increased expression of FAM167A mRNA22378314
C006780bisphenol Abisphenol A results in decreased expression of FAM167A mRNA27685785
C006780bisphenol Abisphenol A affects the expression of FAM167A mRNA25181051
C018475butyraldehydebutyraldehyde results in decreased expression of FAM167A mRNA26079696
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of FAM167A mRNA25596134
C004656chloroacetaldehydechloroacetaldehyde results in decreased expression of FAM167A mRNA25596134
D002737ChloropreneChloroprene results in increased expression of FAM167A mRNA23125180
D003300CopperCopper deficiency results in increased expression of FAM167A mRNA26033743
D016572CyclosporineCyclosporine affects the expression of FAM167A mRNA25596134
D016572CyclosporineCyclosporine results in increased expression of FAM167A mRNA20106945|2798913
C014347decitabinedecitabine affects the expression of FAM167A mRNA23300844
D003907DexamethasoneDexamethasone results in decreased expression of FAM167A mRNA22733784
D003976DiazinonDiazinon results in increased methylation of FAM167A gene22964155
D002945CisplatinCisplatin affects the expression of FAM167A mRNA23300844
D002945CisplatinCisplatin results in decreased expression of FAM167A mRNA25596134
D019422Dietary SucroseDietary Sucrose results in increased expression of FAM167A mRNA26033743
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of FAM167A mRNA28085963
D005411Flame RetardantsFlame Retardants results in increased expression of FAM167A mRNA27219277
D055768Halogenated Diphenyl EthersHalogenated Diphenyl Ethers results in increased expression of FAM167A mRNA27219277
D009532NickelNickel results in decreased expression of FAM167A mRNA24768652
C028007nickel monoxidenickel monoxide results in increased expression of FAM167A mRNA19167457
D010100OxygenOxygen deficiency affects the expression of FAM167A mRNA25596134
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FAM167A mRNA19710929
C027373potassium chromate(VI)potassium chromate(VI) results in increased expression of FAM167A mRNA22714537
D011374ProgesteroneProgesterone results in increased expression of FAM167A mRNA23018184
D011441PropylthiouracilPropylthiouracil results in increased expression of FAM167A mRNA24780913
C513428pyrachlostrobinpyrachlostrobin results in increased expression of FAM167A mRNA27029645
D012822Silicon DioxideSilicon Dioxide analog affects the expression of FAM167A mRNA23806026
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of FAM167A mRNA25895662
D012906SmokeSmoke results in increased expression of FAM167A mRNA21095227
D012999SomanSoman results in increased expression of FAM167A mRNA19281266
D014635Valproic AcidValproic Acid affects the expression of FAM167A mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of FAM167A mRNA23179753|2438349
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of FAM167A gene25560391
C088658zoledronic acidzoledronic acid results in decreased expression of FAM167A mRNA25596134

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IBA21873635  
GO:0005515protein binding-IPI25416956  
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
29207374Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936. (2017 Dec 1)Harris SEAging (Albany NY)